Descartes-11 is an autologous CD8+ anti-BCMA CAR T cell therapy being developed for patients with multiple myeloma.
| SparkCures ID | 347 |
|---|---|
| Developed By | Cartesian Therapeutics |
| Generic Name | Descartes-11 |
| Treatment Classifications |
|
| Treatment Targets |